PANDION THERAPEUTICS, INC. Increase (Decrease) in Accounts Receivable
PANDION THERAPEUTICS, INC. reported Increase (Decrease) in Accounts Receivable of -$85.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2021-03-12
- PANDION THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2020-12-31 was -$1.16M.
- PANDION THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2020-09-30 was $790.00K.
- PANDION THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2020 was -$85.00K, a 108.21% decline from fiscal 2019.
- PANDION THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2019 was $1.03M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$368.00K derived: sum of 2 quarters · filed 2021-03-12 | -$85.00K 10-K · filed 2021-03-12 | |
| 2020-09-30 | $790.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $1.07M 10-Q · filed 2020-11-16 | ||
| 2020-06-30 | $283.00K 10-Q · filed 2020-08-31 | |||
| 2019-12-31 | $1.03M 10-K · filed 2021-03-12 |